Feature Channels:

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Sep-2017 5:05 AM EDT

Tri-Regulator Collaborative Releases Position Statements Addressing Electronic Health Records, Practitioner Burnout

The Tri-Regulator Collaborative, which represents the governing boards of the three organizations representing the state boards that license physicians, physician assistants, nurses, and pharmacists – the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) – have drafted and approved two position statements that highlight the organizations’ shared commitment to protecting public health as well as the common issues faced by the three groups.

Research Provides Clues to Treat Depression, Autism and Other Neuropsychiatric Disorders

Alterations in a naturally occurring chemical in the brain called serotonin have been linked to a number of neuropsychiatric disorders including depression, anxiety and autism. Researchers are revealing critical insights into the mechanisms that can drive diminished serotonin signaling during development and in adulthood to provide new ways of treating several widespread neuropsychiatric disorders associated with perturbed serotonin signaling.

Cedars-Sinai Gastroenterology Pioneer Honored for Excellence in Research and Treatment of Inflammatory Bowel Disease

VIDEO

Stephan R. Targan, MD, a pioneering physician and researcher in gastroenterology, has been awarded the Sherman Prize for groundbreaking work in the understanding and treatment of debilitating inflammatory bowel disease (IBD). Video available at http://www.shermanprize.org/recipient-winners-all/stephan-r-targan-2017-sherman-prize-recipient

ISPOR Undertakes Competencies Initiative for the Field of Health Economics and Outcomes Research

ISPOR announced a new initiative that is focused on the competencies necessary for professionals working in the field of health economics and outcomes research—the ISPOR Health Economics and Outcomes Research Competencies Framework™.

Treatment-Resistant Melanoma May Be Vulnerable to a Drug Holiday, UCLA Study Finds

A UCLA study has uncovered the mechanisms by which treatment-resistant melanoma become vulnerable to cessation of a class of drugs called MAP kinase (MAPK)-targeted inhibitors. By identifying these mechanisms, the scientists discovered that therapeutic benefits for patients could derive from a one-two punch of a drug holiday of MAPK inhibitors followed by a class of drugs called DNA repair inhibitors.

Deprescribing Gets Support From Canada's Seniors, Survey Shows

A majority of Canadians over 65 think "deprescribing" should be a national government priority .

CVS Pharmacy to Acquire Select ProMedica Outpatient Pharmacies

CVS Pharmacy and ProMedica will work together to ensure patients experience a seamless transition of care.

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

/PRNewswire-USNewswire/ -- Nearly 200 academic and industry researchers came together to share updates on preclinical and clinical-stage Alzheimer's disease research at the 18th Annual Conference on Alzheimer's Drug Discovery. The two-day conference, organized by the Alzheimer's Drug Discovery Foundation (ADDF), is the first and only to focus solely on non-amyloid drug programs in development.